Drugs / GSK1247446A
Trials 7 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00545025 | Oct → Dec 2007 | influenza | GlaxoSmithKline | Completed | No outcome recorded |
| Phase 2 | NCT00540228 | Oct 2007 → May 2008 | influenza | GlaxoSmithKline | Completed | No outcome recorded |
| Phase 2 | NCT00385840 | Oct 2006 → Feb 2007 | influenza | GlaxoSmithKline | Completed | No outcome recorded |
| Phase 2 | NCT00374842 | Oct → Nov 2006 | influenza | GlaxoSmithKline | Completed | No outcome recorded |
| Phase 2 | NCT00363077 | Oct → Nov 2006 | influenza | GlaxoSmithKline | Completed | No outcome recorded |
| Phase 2 | NCT00321373 | May → Jul 2006 | influenza | GlaxoSmithKline | Completed | No outcome recorded |
| Phase 2 | NCT00321763 | Apr → Jul 2006 | influenza | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 7 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GSK1247446A | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00540228 ↗ |
| Modality | Vaccine | “received 1 dose of GSK1247446A vaccine adjuvanted with AS03.” NCT00321373 ↗ |
| Route | Intramuscular | “The vaccine was administered intramuscularly in the deltoid region of the non-dominant arm.” NCT00321373 ↗ |